Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancerARNEDOS, Monica; SUTHERLAND, Stephanie; ASHLEY, Sue et al.Breast cancer research and treatment. 2008, Vol 112, Num 1, pp 1-4, issn 0167-6806, 4 p.Article

A randomized controlled trial of aromatherapy massage in a hospice settingSODEN, Katie; VINCENT, Karen; CRASKE, Stephen et al.Palliative medicine. 2004, Vol 18, Num 2, pp 87-92, issn 0269-2163, 6 p.Article

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancerPOPAT, Sanjay; BARBACHANO, Yolanda; ASHLEY, Sue et al.Lung cancer. 2008, Vol 59, Num 2, pp 227-231, issn 0169-5002, 5 p.Article

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerHAWKES, Eliza; OKINES, Alicia F. C; PAPAMICHAEL, Demetris et al.European journal of cancer (1990). 2011, Vol 47, Num 8, pp 1146-1151, issn 0959-8049, 6 p.Article

The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancerBANERJI, Udai; ASHLEY, Sue; COWARD, Jim et al.Lung cancer. 2006, Vol 54, Num 3, pp 371-377, issn 0169-5002, 7 p.Article

Latetoxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United KingdomSHANLEY, Susan; MCREYNOLDS, Kate; ASHCROFT, Linda et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 7025-7032, issn 1078-0432, 8 p.Article

Thirty-day mortality in critical care outreach patients with cancer: An investigative study of predictive factors related to outreach referral episodesPATTISON, Natalie; ASHLEY, Sue; FARQUHAR-SMITH, Paul et al.Resuscitation. 2010, Vol 81, Num 12, pp 1670-1675, issn 0300-9572, 6 p.Article

Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancerPOWLES, Trevor; PATERSON, Sandy; PAJUNEN, Marjo et al.Journal of clinical oncology. 2002, Vol 20, Num 15, pp 3219-3224, issn 0732-183XArticle

The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathyBARTON, Sarah R; SMITH, Ian E; KIRBY, Anna M et al.European journal of cancer (1990). 2011, Vol 47, Num 14, pp 2099-2106, issn 0959-8049, 8 p.Article

Combined use of diffusion-weighted MRI and ¹H MR spectroscopy to increase accuracy in prostate cancer detectionREINSBERG, Stefan A; PAYNE, Geoffrey S; RICHES, Sophie F et al.American journal of roentgenology (1976). 2007, Vol 188, Num 1, pp 91-98, issn 0361-803X, 8 p.Article

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United KingdomSHANLEY, Susan; MCREYNOLDS, Kate; ASHCROFT, Linda et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 7033-7038, issn 1078-0432, 6 p.Article

Establishing an EGFR mutation screening service for non-small cell lung cancer - Sample quality criteria and candidate histological predictorsLEARY, Alexandra F; GONZALEZ DE CASTRO, David; NICHOLSON, Andrew G et al.European journal of cancer (1990). 2012, Vol 48, Num 1, pp 61-67, issn 0959-8049, 7 p.Article

FRACTIONATED STEREOTACTIC RADIOTHERAPY IN THE TREATMENT OF VESTIBULAR SCHWANNOMA (ACOUSTIC NEUROMA): PREDICTING THE RISK OF HYDROCEPHALUSPOWELL, Ceri; MICALLEF, Caroline; GONSALVES, Adam et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 4, pp 1143-1150, issn 0360-3016, 8 p.Article

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classificationMATUTES, Estella; PICKL, Winfried F; PORWIT, Anna et al.Blood. 2011, Vol 117, Num 11, pp 3163-3171, issn 0006-4971, 9 p.Article

Inflammatory Breast Cancer-The Royal Marsden Hospital Experience: A Review of 155 Patients Treated From 1990 to 2007SUTHERLAND, Stephanie; ASHLEY, Sue; WALSH, Geraldine et al.Cancer. 2010, Vol 116, Num 11, pp 2815-2820, issn 0008-543X, 6 p., SUPConference Paper

90-Days mortality rate in patients treated within the context of a phase-I trial : How should we identify patients who should not go on trial?ARKENAU, Hendrik-Tobias; OLMOS, David; JOO ERN ANG et al.European journal of cancer (1990). 2008, Vol 44, Num 11, pp 1536-1540, issn 0959-8049, 5 p.Article

Twenty-year follow-up of the royal marsden randomized, double-blinded tamoxifen breast cancer prevention trialPOWLES, Trevor J; ASHLEY, Sue; TIDY, Alwynne et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 4, pp 283-290, issn 0027-8874, 8 p.Article

Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 TrialOKINES, Alicia F. C; ASHLEY, Sue E; CUNNINGHAM, David et al.Journal of clinical oncology. 2010, Vol 28, Num 25, pp 3945-3950, issn 0732-183X, 6 p.Conference Paper